Literature DB >> 22863214

Localized gastric amyloidosis differentiated histologically from scirrhous gastric cancer using endoscopic mucosal resection: a case report.

Tsugumasa Kamata1, Haruhisa Suzuki, Shigetaka Yoshinaga, Satoru Nonaka, Takeo Fukagawa, Hitoshi Katai, Hirokazu Taniguchi, Ryoji Kushima, Ichiro Oda.   

Abstract

INTRODUCTION: Amyloidosis most often manifests as a systemic involvement of multiple tissues and organs, and an amyloidal deposit confined to the stomach is extremely rare. It is sometimes difficult to provide a definitive diagnosis of localized gastric amyloidosis by biopsy specimen and diagnosis of amyloidosis in some cases has been finalized only after surgical resection of the stomach. CASE
PRESENTATION: A 76-year-old Japanese woman with epigastric discomfort underwent an esophagogastroduodenoscopy procedure. The esophagogastroduodenoscopy revealed gastric wall thickening, suggesting scirrhous gastric carcinoma, at the greater curvature from the upper to the lower part of the gastric corpus. A biopsy specimen revealed amyloid deposits in the submucosal layer with no malignant findings. We resected a representative portion of the lesion by endoscopic mucosal resection using the strip biopsy method to obtain sufficient tissue specimens, and then conducted a detailed histological evaluation of the samples. The resected specimens revealed deposition of amyloidal materials in the gastric mucosa and submucosa without any malignant findings. Congo red staining results were positive for amyloidal protein and exhibited green birefringence under polarized light. Congo red staining with prior potassium permanganate incubation confirmed the light chain (AL) amyloid protein type. Based on these results, gastric malignancy, systemic amyloidosis and amyloid deposits induced by inflammatory disease were excluded and this lesion was consequently diagnosed as localized gastric amyloidosis. Our patient was an older woman and there were no findings relative to an increase in gastrointestinal symptoms or anemia, so no further treatment was performed. She continued to be in good condition without any finding of disease progression six years after verification of our diagnosis.
CONCLUSIONS: We report an unusual case of primary amyloidosis of the stomach resembling scirrhous gastric carcinoma. This case of localized gastric amyloidosis was differentiated from scirrhous gastric cancer after performing endoscopic mucosal resection without an invasive surgical resection, as endoscopic mucosal resection provided sufficient tissue specimens from the lesion to make an accurate histological evaluation.

Entities:  

Year:  2012        PMID: 22863214      PMCID: PMC3438062          DOI: 10.1186/1752-1947-6-231

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Introduction

The term amyloidosis refers to a group of disorders characterized by extracellular accumulation of insoluble, fibrillar proteins in various organs and tissues. Amyloidosis most often manifests as systemic involvement of multiple tissues and organs, and an amyloidal deposit confined to the stomach has been extremely rare in previously published reports. It is sometimes difficult to provide a definitive diagnosis of localized gastric amyloidosis by biopsy specimen and diagnosis of amyloidosis in some cases was definitively made only after surgical resection of the stomach.

Case presentation

A 76-year-old Japanese woman presented to our facility with epigastric discomfort; she had previously undergone an esophagogastroduodenoscopy (EGD) procedure at another hospital. The EGD had revealed gastric wall thickening, suggesting scirrhous gastric carcinoma, so our patient was referred to our hospital for further examination and treatment. A barium upper gastrointestinal X-ray series indicated rigidity and poor extensibility of the gastric wall from the fornix to the lower gastric body, and irregular, enlarged folds were also noticeable (Figure 1). EGD revealed reddish and markedly swollen folds at the greater curvature from the upper to the lower part of the gastric corpus (Figure 2). The mucosa surface was hemorrhagic and erosive. A biopsy specimen revealed amyloid deposits in the submucosal layer with no malignant findings. Endoscopic ultrasound showed obvious thickening of the third layer corresponding to the submucosal layer with no disruption of the gastric wall structure (Figure 3). Computed tomography (CT) revealed thickening of the gastric wall and enlarged circumambient lymph nodes. Biopsy specimens from the rectum and ileum indicated no amyloid deposition. Laboratory test results were negative for Bence-Jones protein in the urine, and serum immunoglobulin levels were normal. No abnormal signs were detected on echocardiography.
Figure 1

Barium upper gastrointestinal X-ray series findings. Barium upper gastrointestinal X-ray series indicating rigidity and poor extensibility of the gastric wall from the upper to lower gastric body.

Figure 2

Esophagogastroduodenoscopy findings. Esophagogastroduodenoscopy revealing reddish and markedly swollen folds with erosions at the greater curvature from the upper to lower part of the gastric corpus.

Figure 3

Endoscopic ultrasound findings. Endoscopic ultrasound showing obvious thickening of the submucosal layer without disruption of the gastric wall structure.

Barium upper gastrointestinal X-ray series findings. Barium upper gastrointestinal X-ray series indicating rigidity and poor extensibility of the gastric wall from the upper to lower gastric body. Esophagogastroduodenoscopy findings. Esophagogastroduodenoscopy revealing reddish and markedly swollen folds with erosions at the greater curvature from the upper to lower part of the gastric corpus. Endoscopic ultrasound findings. Endoscopic ultrasound showing obvious thickening of the submucosal layer without disruption of the gastric wall structure. We resected a representative portion of the lesion by endoscopic mucosal resection (EMR) using the strip biopsy method to obtain sufficient tissue specimens, and we then conducted a detailed histological evaluation (Figure 4). There were no complications associated with the EMR. The resected specimens revealed deposition of amyloidal materials in the gastric mucosa and submucosa with no malignant findings. Congo red staining results were positive for amyloidal protein and exhibited green birefringence under polarized light microscopy. Congo red staining with prior potassium permanganate incubation confirmed the light chain (AL) amyloid protein type. An immunohistochemical examination revealed that κ-chain-positive plasma cells were present only in the inflammatory infiltrate in the superficial lamina propria, while λ-chain-producing plasma cells were detected both in the mucosa and in the underlying lymphomatous proliferation (Figures 5, 6, 7). Based on these results, gastric malignancy, systemic amyloidosis and amyloid deposits induced by inflammatory disease were excluded and the lesion was consequently diagnosed as localized gastric amyloidosis. Our patient was an older woman and there were no findings relative to an increase in gastrointestinal symptoms or anemia, so no further treatment was performed and she continued to be in good condition with no findings of disease progression six years after verification of our diagnosis.
Figure 4

Macroscopic findings from endoscopic mucosal resection (EMR) specimens. Resection of representative portions of lesion by endoscopic mucosal resection was performed using the strip biopsy method.

Figure 5

Pathology results. The resected specimen revealed positive deposition of light chain type amyloidal proteins from both Congo red staining and Congo red staining with prior potassium permanganate incubation.

Figure 6

Polarized microscopy. Polarized microscopy showing green birefringence of deposits.

Figure 7

Immunohistochemical investigation. (a) κ-Chain-positive plasma cells present only in inflammatory infiltrate in the superficial lamina propria. (b) λ-Chain-producing plasma cells detected both in the mucosa and underlying lymphomatous proliferation.

Macroscopic findings from endoscopic mucosal resection (EMR) specimens. Resection of representative portions of lesion by endoscopic mucosal resection was performed using the strip biopsy method. Pathology results. The resected specimen revealed positive deposition of light chain type amyloidal proteins from both Congo red staining and Congo red staining with prior potassium permanganate incubation. Polarized microscopy. Polarized microscopy showing green birefringence of deposits. Immunohistochemical investigation. (a) κ-Chain-positive plasma cells present only in inflammatory infiltrate in the superficial lamina propria. (b) λ-Chain-producing plasma cells detected both in the mucosa and underlying lymphomatous proliferation.

Discussion

The term amyloidosis refers to a group of disorders characterized by extracellular accumulation of insoluble, fibrillar proteins in various organs and tissues [1]. It can result from a heterogeneous group of disorders and cause impairment or even dysfunction of involved organs [2]. Various subtypes exist, including primary systemic amyloidosis, reactive systemic amyloidosis associated with a chronic inflammatory condition and localized forms of aberrant amyloid deposition [3]. Amyloidosis most often manifests as systemic involvement of multiple tissues and organs including the heart, liver, spleen, kidneys, lymph nodes, adrenals and thyroid in addition to many others. The clinical implication of a single organ or tissue is relatively unusual and reports of an amyloidal deposit confined to the stomach are extremely rare in the previously published literature [2,3]. Clinical symptoms of localized gastric amyloidosis are often uncharacteristic and varied, including epigastric discomfort, poor appetite, hematemesis, hematochezia and gastric perforation [2,3]. In addition, the gross appearance of localized gastric amyloidosis also takes various forms such as redness, erosion, ulcer, polypoid mass, thickened folds and scirrhous-like morphology [4]. Its polypoid-mass or scirrhous-like appearance usually tends to be misdiagnosed as a gastric tumor such as gastric cancer or malignant lymphoma due to similarities in gastrointestinal symptoms and gross appearance as revealed by an endoscopic examination and other diagnostic modalities, such as a CT scan. In this respect, it has been suggested that biopsy is the only reliable means to confirm diagnosis [1,5] although it is not always possible to provide a definitive diagnosis from a biopsy specimen, and the diagnosis of amyloidosis has been finalized in some cases only after surgical resection of the stomach [6]. In particular, there have been no published case reports describing scirrhous-like localized gastric amyloidosis diagnosed by biopsy specimen that were subsequently only followed up with no surgical intervention. Therefore, the present case is the first report of scirrhous-like localized gastric amyloidosis diagnosed by a different approach than surgery. The literature review of cases of localized gastric amyloidosis is shown in Table 1.
Table 1

Review of the literature on cases of localized gastric amyloidosis

Age/sexChief issueLocalizationFormAmyloid proteinOperationPrognosisAuthor, year and reference
55/M
Epigastric pain
Lower body
Mucosal redness
Unknown

Survival
Rotondano et al., 2007 [7]
69/F
Left flank pain
Antrum
Mucosal redness
AL

Died (Other disorder)
Yoshida et al., 1998 [8]
58/M
Appetite loss
Lower body
Depression
AA

Survival
Ishii et al., 1993 [9]
50/F
Epigastric discomfort
Lower body
Ulcer
AA
+
Survival
Wu et al., 2003 [2]
63/M
None
Antrum
Ulcer, tumor
AL
+
Survival (18 months)
Nishida et al., 1990 [10]
67/M
Appetite loss
Cardia
Tumor
AL

Survival
Deniz et al., 2006 [3]
51/F
None
Middle body to antrum
Scirrhous type
AL
+
Survival (two months)
Kato et al., 1988 [11]
68/F
Pain, nausea
Antrum
Scirrhous type
Unknown
+
Died (10 months)
Ikeda et al., 1988 [12]
56/M
Obstruction
Unknown
Scirrhous type
Unknown
+
Survival
Nfoussi et al., 2010 [4]
76/FEpigastric discomfortUpper to lower bodyScirrhous typeALSurvival (six years)Present case, 2012
Review of the literature on cases of localized gastric amyloidosis With regard to diagnosis of scirrhous type gastric cancer, histological confirmation using biopsy specimens is also sometimes difficult; accuracy of pre-operative histological diagnosis of scirrhous type gastric cancer has ranged from 58% to 70% in previously published reports [13,14]. In the present case, therefore, the possibility of scirrhous type gastric cancer could not be excluded because of the similarity in gross appearance despite a biopsy specimen indicating amyloid deposits with no malignant findings. Strip biopsy was developed as an EMR technique for early gastric cancer in 1984 [15] and makes it possible to obtain a larger resected specimen compared to a biopsy specimen that enables more precise histological diagnosis. It was particularly important in this case that scirrhous-like localized gastric amyloidosis could be diagnosed by evaluating such precise histological findings from the resected specimen, thereby excluding the existence of scirrhous type gastric cancer by only using EMR without the necessity of performing an invasive surgical resection. Primary amyloidosis refers to the disorder in patients with no preceding or co-existing disease except immunocyte dyscrasis in which the extracellular substance is composed of AL protein produced by plasma cells, as typically seen in multiple myeloma. The major forms of systemic amyloidosis also include reactive systemic amyloidosis consisting of a non-immunoglobulin protein secreted by the liver in the setting of chronic inflammatory disorders or cancers [3]. Localized gastric amyloidosis is characterized by AL type amyloid deposition in the mucosal or submucosal layer of the gastric wall [3,16]. In our patient’s case, deposition of AL type amyloid in the stomach was revealed by detailed histological examination of the EMR specimens, including Congo red staining with prior potassium permanganate incubation. The diagnosis of localized gastric amyloidosis was then confirmed after ruling out systemic amyloid involvement in other organs. Obtaining sufficient tissue specimens from representative changes in our patient’s lesion using EMR, therefore, made it possible to initially perform a detailed histological evaluation including differential staining of elastic fibers and subsequently confirm the localized deposition of AL type amyloid in the stomach. In addition, we were also able to exclude gastric malignancies such as gastric cancer and malignant lymphoma by evaluating those same specimens, so EMR could well become an important diagnostic method for determining localized gastric amyloidosis. Currently, there are no published reports that mention in particular any specific therapy for localized gastric amyloidosis. Some reports have documented that surgical resection with lymph node dissection may be a preferable therapeutic strategy to prevent possible complications such as bleeding and obstruction [2,6]. In contrast, no further treatment is deemed to be necessary in other reports if the patient is symptom free on clinical follow-up. In addition, several reports indicate periodic controls should be scheduled to follow evolution of the disease and facilitate early recognition of multi-organ involvement [3,7]. We did not perform any treatment in this case and there were no subsequent findings of disease progression, but an evaluation involving a large number of patients should be conducted in the future to determine the proper management of localized gastric amyloidosis.

Conclusions

In summary, this rare case of localized gastric amyloidosis was differentiated from scirrhous gastric cancer without performing invasive surgical resection as the use of EMR provided sufficient tissue specimens from the lesion to make an accurate diagnosis of localized deposition of AL type amyloid with no malignant findings possible.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TK was the main contributor to the preparation of the rough draft. HS critically revised the manuscript. HT and RK was involved in histopathological analysis. SY, SN, TF, HK and IO helped to draft the manuscript. All authors read and approved the final manuscript.
  11 in total

Review 1.  Diagnostic tools for amyloidosis.

Authors:  Eric Hachulla; Gilles Grateau
Journal:  Joint Bone Spine       Date:  2002-12       Impact factor: 4.929

Review 2.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

3.  Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis.

Authors:  S Tada; M Iida; A Iwashita; T Matsui; T Fuchigami; T Yamamoto; T Yao; M Fujishima
Journal:  Gastrointest Endosc       Date:  1990 Jan-Feb       Impact factor: 9.427

4.  Localized gastric amyloidosis: a case report.

Authors:  Kemal Deniz; Ismail Sari; Edip Torun; Tahir Ercan Patiroğlu
Journal:  Turk J Gastroenterol       Date:  2006-06       Impact factor: 1.852

5.  [Value of endosonography in diagnosis of diffusely growing stomach carcinomas].

Authors:  U Will; E Zinsser; G Raabe; H Bosseckert
Journal:  Z Gastroenterol       Date:  1998-02       Impact factor: 2.000

6.  Scirrhous carcinoma of the stomach: radiologic and endoscopic diagnosis.

Authors:  M S Levine; V Kong; S E Rubesin; I Laufer; H Herlinger
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

7.  Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy.

Authors:  M Yamada; S Hatakeyama; H Tsukagoshi
Journal:  Hum Pathol       Date:  1985-12       Impact factor: 3.466

8.  Localized amyloidosis of the stomach: a case report.

Authors:  Gianluca Rotondano; Raffaele Salerno; Fabio Cipolletta; Maria Antonia Bianco; Antonino De Gregorio; Raffaele Miele; Antonio Prisco; Maria Lucia Garofano; Livio Cipolletta
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

9.  A case report of localized gastric amyloidosis.

Authors:  Dan Wu; Jian-Ying Lou; Jian Chen; Lun Fei; Gui-Jie Liu; Xiao-Yu Shi; Han-Ting Lin
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

10.  A case of amyloid tumor of the stomach.

Authors:  K Ikeda; H Murayama
Journal:  Endoscopy       Date:  1978-02       Impact factor: 10.093

View more
  6 in total

1.  Tissue sampling using a submucosal tunnelling technique for indefinite gastric amyloidosis.

Authors:  Hideki Kobara; Makoto Oryu; Hirohito Mori; Shintaro Fujihara; Noriko Nishiyama; Yasuhiro Goda; Taiga Chiyo; Tae Matsunaga; Maki Ayaki; Tatsuo Yachida; Toshiaki Nakatsu; Tsutomu Masaki
Journal:  Can J Gastroenterol Hepatol       Date:  2015-03

Review 2.  Localized amyloidosis of the stomach mimicking a superficial gastric cancer.

Authors:  Miwako Kagawa; Yasuteru Fujino; Naoki Muguruma; Noriaki Murayama; Koichi Okamoto; Shinji Kitamura; Tetsuo Kimura; Kazuhiro Kishi; Hiroshi Miyamoto; Hisanori Uehara; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-05-12

3.  Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression.

Authors:  Yong Hwan Ahn; Ye Young Rhee; Suck Chei Choi; Geom Seog Seo
Journal:  Clin Endosc       Date:  2017-10-26

Review 4.  Primary localized gastric amyloidosis: A scoping review of the literature from clinical presentations to prognosis.

Authors:  Xin-Yu Lin; Dan Pan; Li-Xuan Sang; Bing Chang
Journal:  World J Gastroenterol       Date:  2021-03-28       Impact factor: 5.742

5.  Primary systemic amyloidosis with extensive gastrointestinal involvement.

Authors:  V Gaduputi; K Badipatla; H Patel; H Tariq; A Ihimoyan
Journal:  Case Rep Gastroenterol       Date:  2013-12-12

6.  Localized Gastric Amyloidosis that Displayed Morphological Changes over 10 Years of Observation.

Authors:  Yasushi Takahashi; Waku Hatta; Tomoyuki Koike; Yohei Ogata; Taku Fujiya; Masahiro Saito; Xiaoyi Jin; Kenichiro Nakagawa; Takeshi Kanno; Kiyotaka Asanuma; Kaname Uno; Naoki Asano; Akira Imatani; Fumiyoshi Fujishima; Nagaaki Katoh; Tsuneaki Yoshinaga; Atsushi Masamune
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.